vaccine
Showing 1 - 25 of >10,000
Unrecognized Condition Trial in Merkez (Vaccine Education Program Based on Integrated Change Model)
Not yet recruiting
- Unrecognized Condition
- Vaccine Education Program Based on Integrated Change Model
-
Merkez, Artvin, TurkeyDeniz S. Sümeyye YORULMAZ
Jun 30, 2023
SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,
Not yet recruiting
- SARS-CoV-2 Infection
- +4 more
- Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023
Vaccine Response Trial in Atlanta (Atorvastatin, Quadrivalent seasonal influenza vaccine)
Not yet recruiting
- Vaccine Response
- Atorvastatin
- Quadrivalent seasonal influenza vaccine
-
Atlanta, GeorgiaHope Clinic
Aug 29, 2023
Meningococcal Infection (Healthy Volunteers) Trial in Middelburg (Meningococcal Polysaccharide (Serogroups A, C, Y, and W)
Recruiting
- Meningococcal Infection (Healthy Volunteers)
- Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
- +11 more
-
Middelburg, South AfricaInvestigational Site Number: 7100001
Apr 4, 2023
Vaccine Refusal, Vaccine-Preventable Diseases, Physician-Patient Relations Trial in Royal Oak (Immersive resident education,
Not yet recruiting
- Vaccine Refusal
- +2 more
- Immersive resident education
- Standardized patient (SP) encounter
-
Royal Oak, MichiganBeaumont Health System
Oct 5, 2023
Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)
Not yet recruiting
- Influenza, Human
- sa-mRNA vaccine Dose 1
- +4 more
- (no location specified)
Sep 7, 2023
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults
Recruiting
- Influenza
- +2 more
- Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
- High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
-
Oakland, CaliforniaKaiser Permanente Northern California (entire region)
Sep 1, 2023
Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single
Not yet recruiting
- Safety of a Single Dose of COMVIGEN Vaccine
- +5 more
- Comvigen (Bivalent, ChulaCov19 BNA159.2)
- BIVALENT Pfizer/BNT vaccine
-
Bangkok, Thailand
- +1 more
Jun 29, 2023
Vaccine Hesitancy Trial (Multilevel Intervention)
Not yet recruiting
- Vaccine Hesitancy
- Multilevel Intervention
- (no location specified)
Nov 30, 2023
Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine
Not yet recruiting
- Influenza, Human
- ARCT-2138
- +2 more
-
Brisbane, Queensland, AustraliaNucleus Network Brisbane Clinic
Nov 8, 2023
Vaccine Acceptance Trial in New York (Peer-led vaccine education intervention)
Recruiting
- Vaccine Acceptance
- Peer-led vaccine education intervention
-
New York, New YorkNYU Grossman School of Medicine, Division of Infectious Diseases
May 16, 2023
Vaccine-Preventable Diseases, COVID-19 Pandemic, Health-Related Behavior Trial (Baseline surveys, Digital Storytelling
Not yet recruiting
- Vaccine-Preventable Diseases
- +4 more
- Baseline surveys
- +2 more
- (no location specified)
Sep 12, 2023
Diphtheria, Tetanus and Acellular Pertussis Trial (Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined
Not yet recruiting
- Diphtheria, Tetanus and Acellular Pertussis
- Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTcP)
- +4 more
- (no location specified)
Jul 10, 2023
Influenza Trial in Bangkok (TetraFluvac TF vaccine, Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023)
Not yet recruiting
- Influenza
- TetraFluvac TF vaccine
- Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023
-
Bangkok, ThailandVaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
May 30, 2023
IsThird Dose of MMRV Vaccine Beneficial for Adult Population in
Not yet recruiting
- Vaccination Failure
- Vaccine Response Impaired
- Serology for antibody levels - Baseline
- +3 more
- (no location specified)
Jun 26, 2023
Vaccine Hesitancy Trial in Dwarka (Happy Baby Programme -Vaccine Campaign, Happy Baby Programme- Vaccine ++ Campaign)
Not yet recruiting
- Vaccine Hesitancy
- Happy Baby Programme -Vaccine Campaign
- Happy Baby Programme- Vaccine ++ Campaign
-
Dwārka, New Delhi, IndiaD-COR (Development Corner) Consulting
Aug 16, 2023
Healthy Volunteers Trial in Dhaka (ShigETEC live, attenuated, oral vaccine, Placebo)
Not yet recruiting
- Healthy Volunteers
- ShigETEC live, attenuated, oral vaccine
- Placebo
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Diseases Research, Banglades
Aug 3, 2023
COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for
Not yet recruiting
- COVID-19
- SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
- SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
-
Manila, Philippines
- +2 more
Jun 21, 2023
SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10
Recruiting
- SARS-CoV-2 Infection
- Placebo
- +4 more
-
Hangzhou, Zhejiang, ChinaShulan (Hangzhou) Hospital
Nov 7, 2023
Pneumonia, Pneumococcal, Vaccine Trial (Pneumococcal Vaccine Education)
Not yet recruiting
- Pneumonia, Pneumococcal
- Vaccine
- Pneumococcal Vaccine Education
- (no location specified)
Nov 13, 2023
Vaccine-Preventable Diseases, Herpes Zoster Trial in Zhenjiang (Recombinant Herpes Zoster Vaccine, Recombinant Herpes Zoster
Recruiting
- Vaccine-Preventable Diseases
- Herpes Zoster
- Recombinant Herpes Zoster Vaccine
- Recombinant Herpes Zoster Vaccine Placebo
-
Zhenjiang, Jiangsu, ChinaJiangsu Province Center for Disease Control and Prevention (Chin
Oct 12, 2023
Hand, Foot and Mouth Disease, Herpangina Trial in Chuxiong (low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated,
Recruiting
- Hand, Foot and Mouth Disease
- Herpangina
- low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
- +3 more
-
Chuxiong, Yunnan, ChinaDayao County Center for Disease Control and Prevention
Sep 25, 2023
Tumor Vaccine Benefit for Gliomas
Recruiting
- Glioma
- DC vaccine
-
Shanghai, ChinaHuashan Hospital,Fudan University
Sep 12, 2023
Rabies Vaccine Adverse Reaction Trial in Changsha (Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose
Completed
- Rabies Vaccine Adverse Reaction
- Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program
- +3 more
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Oct 9, 2023
Aging Trial (vaccine)
Not yet recruiting
- Aging
- vaccine
- (no location specified)
Nov 8, 2023